Search by Drug Name or NDC
NDC 00093-8739-01 Mexiletine Hydrochloride 150 mg/1 Details
Mexiletine Hydrochloride 150 mg/1
Mexiletine Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is MEXILETINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Mexiletine is used to treat certain types of ventricular arrhythmias (abnormal heart rhythms). Mexiletine is in a class of medications called antiarrhythmics. It works by blocking certain electrical signals in the heart to stabilize the heart rhythm.
Related Packages: 00093-8739-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mexiletine
Product Information
| NDC | 00093-8739 |
|---|---|
| Product ID | 0093-8739_e7a9997c-4cf7-4cf1-94c0-ff60f15ae0f9 |
| Associated GPIs | 35200025100105 |
| GCN Sequence Number | 000267 |
| GCN Sequence Number Description | mexiletine HCl CAPSULE 150 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 12210 |
| HICL Sequence Number | 000084 |
| HICL Sequence Number Description | MEXILETINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Mexiletine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Mexiletine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | MEXILETINE HYDROCHLORIDE |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA074377 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00093-8739-01 (00093873901)
| NDC Package Code | 0093-8739-01 |
|---|---|
| Billing NDC | 00093873901 |
| Package | 100 CAPSULE in 1 BOTTLE (0093-8739-01) |
| Marketing Start Date | 1995-06-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.32213 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | MEXILETINE 150 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis